Introduction
Irritable bowel syndrome (IBS) is a heterogeneous disorder of gut-brain interactions characterised by pain and altered bowel habits1. The low fermentable oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet is efficacious for improving symptoms and quality of life (QoL)2, however not all individuals will have a therapeutic response resulting in adequate symptom relief3. Behavioural, emotional and cognitive predictors of response have been explored in psychological therapies, but not in dietary treatments of IBS4.
Aims & Methods
The aim of this study was to identify psychological predictors of treatment response to the low FODMAP diet. Participants underwent a three-phase dietitian-led low FODMAP diet between August 2018 and July 2021. Participants completed questionnaires to obtain scores for psychological factors and symptoms (predictor variables). Data on depression, anxiety, gastrointestinal (GI) specific anxiety, somatic symptoms, illness perceptions, behavioural avoidance, treatment beliefs and expectations, symptom severity and QoL was collected at five time points; pre dietitian (week 0), post dietitian (week 1), post FODMAP restriction (week 5), post FODMAP reintroduction (week 13) and personalisation (week 25). Linear mixed models (LMM) were used to test the effect of baseline psychological scores on IBS symptoms and QoL over time. Cross lag panel models (CLPM) were used to identify directional relationships between predictor variables on the one hand, and IBS symptoms and QoL on the other.
Results
112 participants, (89% female, median age 30 ± 17 years) were included. LMM showed that higher treatment beliefs predicted a stronger initial symptom response (effect on linear slope p=0.036). Of the illness perceptions, lower emotional representations predicted a stronger initial and later QoL response (effect on linear (p=0.006) and quadratic (p=0.049) slopes). Increased cyclical time beliefs predicted poorer initial and later QoL response (effect on linear (p=0.015) and quadratic (p=0.029) slopes). CLPM showed that lower GI specific anxiety predicted a stronger reduction in symptoms from week 0 to 25. Of the illness perceptions, positive perceptions relating to higher personal and treatment control predicted a stronger reduction in symptoms from week 0 to week 25. Increased QoL predicted reductions in GI specific anxiety and stress from week 0 to week 25 and week 1 to week 25, respectively. Increased personal and treatment control predicted improved QoL across all time points.
Conclusion
Negative illness perceptions were associated with poorer symptom and QoL response, whereas positive illness perceptions and treatment beliefs predicted better QoL and symptom responses to the low FODMAP diet in adults with IBS. Illness perceptions and treatment beliefs can be easily assessed in clinical practice and should be considered when determining if the low FODMAP diet is a suitable treatment, and may serve as targets to enhance treatment response.
References
1Camileri, M & Dilmaghani, S. (2023). Update on treatment of abdominal pain in irritable bowel syndrome: a narrative review. Pharmacology and therapeutics, 245, 108400-108400. http://doi.org/10.1016/j.pharmthera.2023.108400
2van Lanen, A.S., de Bree, A & Greyling, A. (2021). Efficacy of a low FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr, 60(6), 3505-3522. doi:10.1007/s00394-020-02437-0
3Wilson, B., Cox, S.R. & Whelan, K. (2021). Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc, 80(1), 19-8. doi:10.1017/s0029665120006990
4 Radu, M., Moldovan, R., Pintea, S., Baban, A & Dumitrascu. (2018). Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis. Journal of Gastrointestinal and Liver Diseases, 27(3), 257-263. http://dx.doi.org/10.15403/jgld.2014.1121.273.bab